JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2004) 183, 183-194    DOI: 10.1677/joe.1.05647
© 2004 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cha, D. R.
Right arrow Articles by Kim, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cha, D. R.
Right arrow Articles by Kim, N. H.

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats

Dae Ryong Cha1, Young Sun Kang1, Sang Youb Han2, Yi Hwa Jee1, Kum Hyun Han1, Jee Young Han3, Young Sik Kim4 and Nan Hee Kim1

1 Department of Internal Medicine, College of Medicine, Korea University, Ansan, South Korea
2 Department of Internal Medicine, College of Medicine, Inje University, Ilsan, South Korea
3 Department of Anatomical Pathology, Inha University, Incheon, South Korea
4 Department of Anatomical Pathology, College of Medicine, Korea University, Ansan, South Korea

(Requests for offprints should be addressed to Nan Hee Kim, Department of Internal Medicine, Korea University Hospital, 516 Kojan-Dong, Ansan City, Kyungki-Do, 425-020, South Korea; Email: nhkim{at}kumc.or.kr)

Vascular endothelial growth factor (VEGF) has been implicated in the pathogenesis of diabetic nephropathy. We investigated serial changes of VEGF in the kidney and assessed whether glomerular and urinary VEGF levels are related to the severity of diabetic nephropathy. Furthermore, we examined the relationship between urinary VEGF levels and the urinary albumin excretion (UAE) rate in Otsuka-Long-Evans-Tokushima-Fatty (OLETF) rats. Glomerular VEGF mRNA expression and protein synthesis were evaluated by the reverse transcription-polymerase chain reaction, immunohistochemical staining and in situ hybridization. Urinary levels of VEGF were determined by enzyme-linked immunosorbent assay. UAE was significantly higher in OLETF rats than in control Long-Evans-Tokushima-Fatty (LETO) rats throughout the study period. Urinary VEGF levels were significantly higher from 25 to 37 weeks, and then gradually reduced until 55 weeks, although the levels were still higher than those in control rats. Urinary VEGF levels also showed a significant positive correlation with UAE (r=0.262, P=0.045) and serum creatinine (r=0.398, P=0.044), and were found to be independently correlated with UAE by Spearman’s rank correlation. By immunohistochemical staining and in situ hybridization, VEGF was mainly detected in the podocytes in the glomeruli. Interestingly, a significant increase in VEGF mRNA expression was observed in the early period of diabetic nephropathy, and this was associated with increased urinary VEGF excretion. Thus, the overproduction of VEGF in the diabetic kidney may participate in the pathogenesis of early-stage diabetic nephropathy.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. A. Varghese, T. B. Powell, M. N. Budisavljevic, J. C. Oates, J. R. Raymond, J. S. Almeida, and J. M. Arthur
Urine Biomarkers Predict the Cause of Glomerular Disease
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 913 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen
Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3093 - 3104.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
Y. S. Kang, Y. G. Park, B. K. Kim, S. Y. Han, Y. H. Jee, K. H. Han, M. H. Lee, H. K. Song, D. R. Cha, S. W. Kang, et al.
Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
J. Mol. Endocrinol., April 1, 2006; 36(2): 377 - 388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Mariappan, D. Senthil, K. S. Natarajan, G. G. Choudhury, and B. S. Kasinath
Phospholipase C{gamma}-Erk Axis in Vascular Endothelial Growth Factor-induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells
J. Biol. Chem., August 5, 2005; 280(31): 28402 - 28411.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Wang, T. Jiang, J. Li, G. Proctor, J. L. McManaman, S. Lucia, S. Chua, and M. Levi
Regulation of Renal Lipid Metabolism, Lipid Accumulation, and Glomerulosclerosis in FVBdb/db Mice With Type 2 Diabetes
Diabetes, August 1, 2005; 54(8): 2328 - 2335.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.